Wedmont Private Capital’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,244
Closed -$254K 876
2025
Q4
$254K Buy
5,244
+616
+13% +$30.5K 0.01% 691
2025
Q3
$228K Sell
4,628
-739
-14% -$35.7K 0.01% 708
2025
Q2
$262K Sell
5,367
-383
-7% -$19.6K 0.01% 628
2025
Q1
$296K Buy
5,750
+321
+6% +$17.4K 0.02% 528
2024
Q4
$265K Buy
5,429
+154
+3% +$7.83K 0.01% 572
2024
Q3
$289K Buy
5,275
+542
+11% +$29.3K 0.02% 521
2024
Q2
$243K Buy
+4,733
New +$228K 0.02% 555

Other funds holding SNY

Wedmont Private Capital's SNY Position: Q1 2026 in Review

Wedmont Private Capital sold out of Sanofi (SNY) in Q1 2026, closing a stake of 5,244 shares — an estimated $254K sold.

Wedmont Private Capital first reported a position in SNY in Q2 2024 and held it in 7 quarters. The position peaked at $296K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Wedmont Private Capital reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Wedmont Private Capital sold 5,244 Sanofi shares in Q1 2026, an estimated $254K.
  • Wedmont Private Capital first reported a position in Sanofi in Q2 2024 and held it in 7 quarters.
  • Wedmont Private Capital's Sanofi position peaked at $296K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Wedmont Private Capital's 13F filing for Q1 2026, filed 9 Apr 2026.